About Endopure

in January 2019, Endopure deliberately withdrew CBD food supplements from the UK market in compliance with Novel Food & Home Office regulations. Then in December 2019, TTS Pharma became the first UK company to submit a Novel Food dossier to the European Food Safety Authority (EFSA), establishing their position as a leading supplier of safe & ethical CBD Food products.

In April 2020, TTS Pharma received written permission to place CBD food supplement products onto the UK market ahead of its Novel Food application being approved. This Assured Advice means that our Food Supplements can be placed on the market in compliance with published FSA & Home Office guidelines. Pending Novel Food approval expected during 2021, this important milestone introduces long overdue quality & compliance into the UK CBD market.

We don’t mess around or cut corners when it comes to consumer safety. We invest heavily in internal quality resources and systems that monitor safety and compliance within our entire supply chain, flagging any quality or safety issues before they have a chance to occur.

We further ensure that all of our products undergo extensive independent analysis from one of the World’s leading food safety authorities and one of few UK government accredited testing laboratories. Our Supplements are screened for controlled drugs Tetrahydrocannabinol (THC), Tetrahydrocannabinol Acid (THC-a), Tetrahydrocannabivarin (THC-v) and Cannabinol (CBN) with state-of-the-art instruments that can detect within 0.00025% or 2.5mg/kg.

Whilst our Hemp crops are certified organic, we provide extra assurance inline with EU regulations and screen for various pesticides, mycotoxins, heavy metals & other known contaminants inherent with Hemp cultivation, especially in some popular growing regions throughout the world.